Eligibility for WHO shorter MDR treatment regimen among foreign-born MDR PTB patients in Singapore
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa4854
Abstract: In May 2016, the WHO recommended a 9-12 month MDR-TB treatment regimen for pulmonary MDR-TB patients without confirmed resistance to a medicine in this regimen (excluding isoniazid resistance). The majority of MDR pulmonary TB (PTB)… read more here.
Keywords: shorter mdr; mdr; resistance; treatment regimen ... See more keywords
Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study
Sign Up to like & getrecommendations! Published in 2021 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-021-05967-2
Abstract: Background The World Health Organization (WHO) End TB strategy aims to reduce mortality due to tuberculosis (TB) to less than 5% by 2035. However, mortality due to multidrug-resistant tuberculosis (MDR-TB) remains particularly high. Globally, almost… read more here.
Keywords: treatment; risk factors; mortality; tuberculosis ... See more keywords